 Zhiwei Sun
Concepts (67)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Lipoprotein | 1 | 2026 | 15 | 0.940 |
Why?
| | Intestinal Absorption | 1 | 2026 | 103 | 0.900 |
Why?
| | Dietary Fats | 1 | 2026 | 308 | 0.810 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2026 | 231 | 0.800 |
Why?
| | Membrane Glycoproteins | 2 | 2025 | 499 | 0.360 |
Why?
| | Obesity | 1 | 2026 | 3118 | 0.360 |
Why?
| | Chylomicrons | 1 | 2026 | 18 | 0.240 |
Why?
| | Lipoproteins, HDL | 1 | 2026 | 100 | 0.230 |
Why?
| | TNF Receptor-Associated Factor 6 | 1 | 2025 | 6 | 0.220 |
Why?
| | Intestine, Small | 1 | 2026 | 167 | 0.220 |
Why?
| | Osteosarcoma | 1 | 2025 | 89 | 0.200 |
Why?
| | Neuroendocrine Tumors | 1 | 2025 | 119 | 0.200 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2025 | 178 | 0.200 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 1 | 2025 | 153 | 0.200 |
Why?
| | Chlorogenic Acid | 1 | 2022 | 4 | 0.190 |
Why?
| | Toll-Like Receptor 4 | 1 | 2025 | 276 | 0.190 |
Why?
| | Bone Neoplasms | 1 | 2025 | 265 | 0.180 |
Why?
| | Periodontitis | 1 | 2022 | 55 | 0.180 |
Why?
| | Immunotherapy, Adoptive | 1 | 2025 | 342 | 0.170 |
Why?
| | NF-kappa B | 1 | 2025 | 667 | 0.170 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2025 | 883 | 0.150 |
Why?
| | Mice, Knockout | 1 | 2026 | 3130 | 0.140 |
Why?
| | Mice | 6 | 2026 | 18357 | 0.140 |
Why?
| | Pancreatic Neoplasms | 1 | 2025 | 928 | 0.120 |
Why?
| | Triterpenes | 1 | 2017 | 27 | 0.120 |
Why?
| | Fluorescent Dyes | 1 | 2017 | 334 | 0.110 |
Why?
| | Mice, Inbred C57BL | 1 | 2026 | 5992 | 0.110 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2017 | 592 | 0.110 |
Why?
| | Animals | 6 | 2026 | 38100 | 0.100 |
Why?
| | Antineoplastic Agents | 1 | 2025 | 2219 | 0.100 |
Why?
| | Omeprazole | 1 | 2011 | 9 | 0.080 |
Why?
| | Ticlopidine | 1 | 2011 | 52 | 0.080 |
Why?
| | Angioplasty, Balloon, Coronary | 1 | 2011 | 156 | 0.080 |
Why?
| | Neoplasms | 1 | 2025 | 2913 | 0.070 |
Why?
| | Acute Coronary Syndrome | 1 | 2011 | 297 | 0.060 |
Why?
| | Molecular Docking Simulation | 1 | 2025 | 119 | 0.050 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2025 | 194 | 0.050 |
Why?
| | Neoplasms, Experimental | 1 | 2025 | 167 | 0.050 |
Why?
| | Angiogenesis Inhibitors | 1 | 2025 | 239 | 0.050 |
Why?
| | Structure-Activity Relationship | 1 | 2025 | 563 | 0.050 |
Why?
| | Tumor Cells, Cultured | 1 | 2025 | 887 | 0.050 |
Why?
| | Mice, Nude | 1 | 2025 | 680 | 0.050 |
Why?
| | Povidone | 1 | 2022 | 6 | 0.050 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2025 | 936 | 0.040 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2025 | 457 | 0.040 |
Why?
| | Delayed-Action Preparations | 1 | 2022 | 189 | 0.040 |
Why?
| | Humans | 5 | 2026 | 145750 | 0.040 |
Why?
| | Tumor Microenvironment | 1 | 2025 | 735 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2025 | 2028 | 0.040 |
Why?
| | Male | 2 | 2026 | 72992 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2022 | 611 | 0.040 |
Why?
| | Mice, Transgenic | 1 | 2025 | 2191 | 0.040 |
Why?
| | Lipopolysaccharides | 1 | 2022 | 858 | 0.040 |
Why?
| | Antioxidants | 1 | 2022 | 550 | 0.040 |
Why?
| | Antibodies, Monoclonal | 1 | 2025 | 1505 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2025 | 3551 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2025 | 2514 | 0.030 |
Why?
| | Biological Availability | 1 | 2017 | 145 | 0.030 |
Why?
| | Cytokines | 1 | 2022 | 2069 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2025 | 4569 | 0.030 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1925 | 0.020 |
Why?
| | Signal Transduction | 1 | 2025 | 5223 | 0.020 |
Why?
| | Aspirin | 1 | 2011 | 406 | 0.020 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2011 | 499 | 0.020 |
Why?
| | Female | 2 | 2017 | 79025 | 0.010 |
Why?
| | Aged | 1 | 2011 | 26212 | 0.010 |
Why?
| | Middle Aged | 1 | 2011 | 36297 | 0.000 |
Why?
|
|
Sun's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|